Skip to content

Search Results

989 Results

World AIDS Day

  • Depression, Patients and Families

World AIDS Day, Dec. 1, is a time to remember, to educate and to decrease stigma around HIV/AIDS. The theme of this year@s World AIDS Day is @Communities Make the Difference,@ recognizing the essential role that communities have played supporting people living with HIV and advocating for better access to prevention and treatment. For people with HIV, it’s important to take care of both physical health and mental health. People with HIV have increased risk for mental health problems.

FDA Approves Novel Depression Treatment

  • Depression, Patients and Families

Last month, esketamine nasal spray became the first treatment for depression with a new mechanism of action approved by the Food and Drug Administration (FDA) since Prozac (fluoxetine hydrochloride) was approved in the late 1980s. Esketamine (sold as Spravato) has the potential to be extremely useful for people who have not responded to other treatments. Used in combination with an oral anti-depressant, it can take effect much faster than many common antidepressant medications. However, it comes

African Americans Face a Greater Risk of Alzheimer’s

  • Older adults, Patients and Families

Alzheimer’s is the most common cause of dementia and it affects about one-third of adults age 85 and older in the U.S., but some populations are disproportionally impacted. For instance, African Americans are about twice as likely as whites to have Alzheimer’s or other dementias.

Master Your Profession with In-Depth Master Courses

The paid Master Courses are full-day, in-depth events within the event. Multiple expert faculty lead each Master Course in a hands-on way. All day long, they focus on deep, actionable knowledge to enhance your practice around real-world, everyday topics and challenges.

Advocacy Action Center

Help shape legislation that advances your profession and promote the highest quality of care for your patients and their families

Genetic Testing to Improve Psychiatric Medication Choice

  • Depression, Patients and Families, Serious mental illness

Genetic testing is being marketed and used for a variety of different purposes, such as confirming or ruling out a suspected genetic condition or helping determine a person’s chance of developing or passing on a genetic disorder. It is also being marketed to improve the selection of medication for mental illness, such as depression. However, several recent expert reviews caution that while it holds much potential, the evidence does not yet show genetic testing is effective in improving psychiatr

Caring for Pregnant Women: A Psychiatrist’s Guide

  • Depression, Patients and Families, Treatment, Women

Every psychiatrist will see a pregnant woman or other patient who is pregnant someday. When that person presents to your office, will you be ready? Many of us received little if any training on the subject, so the American Psychiatric Association’s Committee on Women’s Mental Health would like to help. Read on for five things every psychiatrist needs to know before a pregnant patient walks in your door.

American Psychiatric Association, American Telemedicine Association, ATA Action and 69 Other Groups Call on Administration to Permanently Remove Barriers to Care

Today, 72 organizations asked the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) to permanently waive the requirement that patients receive an in-person evaluation prior to being prescribed controlled substances via telemedicine. The organizations, convened by the American Psychiatric Association, the American Telemedicine Association, and ATA Action submitted the letter to the DEA as it is currently developing the Special Registration process for the

Medical leadership for mind, brain and body.

Join Today